Linda Elsegood
The LDN Book 3
Low Dose Naltrexone
Paperback EN 2022 9781739107000Levertijd ongeveer 11 werkdagen
Gratis verzonden
Samenvatting
Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers. It has been used to help those with autism, chronic fatigue, and depression find relief, and latest research points to its potential for long covid, mold toxicity, even longevity. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? Find out more about the potential of LDN from leading international medical professionals in this updated, third book, edited by Linda Elsegood, founder of The LDN Trust.
Specificaties
ISBN13:9781739107000
Taal:EN
Bindwijze:Paperback
Aantal pagina's:316
Uitgever:LDN Research Trust
Lezersrecensies
Wees de eerste die een lezersrecensie schrijft!
Rubrieken
- advisering
- algemeen management
- coaching en trainen
- communicatie en media
- economie
- financieel management
- inkoop en logistiek
- internet en social media
- it-management / ict
- juridisch
- leiderschap
- marketing
- mens en maatschappij
- non-profit
- ondernemen
- organisatiekunde
- personal finance
- personeelsmanagement
- persoonlijke effectiviteit
- projectmanagement
- psychologie
- reclame en verkoop
- strategisch management
- verandermanagement
- werk en loopbaan